AustralianSuper Gets Small Exposure to Irish Biotech

Posted on 05/29/2014


Dublin-based Heart Metabolics Limited is a biotechnology company focused on the advancement of drugs for cardio-metabolic diseases. On April 17, Heart Metabolics raised US$20 million Series A financing from venBio, Seroba Kernel Life Sciences, Melbourne-based Brandon Capital Partners (on behalf of AustralianSuper) and AshHill. Heart Metabolics is developing perhexiline as a new therapy for congestive […]

Get News, People, and Transactions, Delivered to Your Inbox